Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.
Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Singh A, Gupta A, Chilkoti DC. Mohanty L, et al. Among authors: singh a. Hum Vaccin Immunother. 2017 Sep 2;13(9):2025-2031. doi: 10.1080/21645515.2017.1342020. Epub 2017 Jul 12. Hum Vaccin Immunother. 2017. PMID: 28700282 Free PMC article. Clinical Trial.
A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants.
Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Gupta A, Chilkoti DC, Singh A. Mohanty L, et al. Among authors: singh a. Vaccine. 2018 Apr 19;36(17):2378-2384. doi: 10.1016/j.vaccine.2017.09.029. Epub 2018 Mar 23. Vaccine. 2018. PMID: 29580640 Clinical Trial.
Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.
Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM. Mohan VK, et al. Among authors: singh a. Clin Infect Dis. 2015 Aug 1;61(3):393-402. doi: 10.1093/cid/civ295. Epub 2015 Apr 13. Clin Infect Dis. 2015. PMID: 25870324 Clinical Trial.
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.
Shah S, Nandy RK, Sethi SS, Chavan B, Pathak S, Dutta S, Rai S, Singh C, Chayal V, Patel C, Kumar NR, Chavan AT, Chawla A, Singh A, Roy AK, Singh N, Baik YO, Lee Y, Park Y, Jeong KH, Ahmed S. Shah S, et al. Among authors: singh n, singh c, singh a. Lancet Reg Health Southeast Asia. 2023 Aug 24;19:100256. doi: 10.1016/j.lansea.2023.100256. eCollection 2023 Dec. Lancet Reg Health Southeast Asia. 2023. PMID: 38076719 Free PMC article.
A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains.
Singh A, Mitra M, Sampath G, Venugopal P, Rao JV, Krishnamurthy B, Gupta MK, Sri Krishna S, Sudhakar B, Rao NB, Kaushik Y, Gopinathan K, Hegde NR, Gore MM, Krishna Mohan V, Ella KM. Singh A, et al. J Infect Dis. 2015 Sep 1;212(5):715-25. doi: 10.1093/infdis/jiv023. Epub 2015 Jan 18. J Infect Dis. 2015. PMID: 25601942 Clinical Trial.
Farm exposure is associated with human breast milk immune profile and microbiome.
Swaney MH, Steidl OR, Tackett A, Fye S, Lee KE, Ong IM, Bendixsen C, Spicer G, DeLine J, Gern JE, Lucey J, Seroogy CM, Kalan L, Singh AM. Swaney MH, et al. bioRxiv [Preprint]. 2024 Oct 14:2024.10.14.618271. doi: 10.1101/2024.10.14.618271. bioRxiv. 2024. PMID: 39464075 Free PMC article. Preprint.
25,307 results
You have reached the last available page of results. Please see the User Guide for more information.